All Stories

  1. Targeting Oxalate Production by Combining Enzyme Inhibition and Proteolysis Activation: A Novel Therapeutic Approach for Primary Hyperoxaluria Type 1
  2. Synthesis, Spectroscopic Characterization, Drug‐Likeness, and Antibacterial Activity of a Novel Triazole Derivative
  3. Molecular dynamics, docking and quantum calculations reveal conformational changes influenced by CYP271A amino acid mutations related to cerebrotendinous xanthomatosis
  4. Solvation effects, structural, vibrational analysis, chemical reactivity, nanocages, ELF, LOL, docking and MD simulation on Sitagliptin
  5. Daidzein and Equol: Ex Vivo and In Silico Approaches Targeting COX-2, iNOS, and the Canonical Inflammasome Signaling Pathway
  6. Synthesis, Solvent effects, Chemical reactivity, Molecular Docking and Molecular Dynamic Studies of Triazole derivative
  7. Editorial: Use of computational tools for designing epigenetic drugs
  8. Molecular insight into endosulfan degradation by Ese protein from Arthrobacter: Evidence‐based structural bioinformatics and quantum mechanical calculations
  9. Design and simulation of a caprylic acid enzymatically modified phosphatidylcholine micelle using a coarse-grained molecular dynamics simulations approach
  10. Cytotoxic evaluation of YSL-109 in a triple negative breast cancer cell line and toxicological evaluations
  11. Synthesis, characterization, molecular docking and molecular dynamics simulations of benzamide derivatives as potential anti-ovarian cancer agents
  12. An investigation on the molecular structure, interaction with metal clusters, anti-Covid-19 ability of 2-deoxy-D-glucose: DFT calculations, MD and docking simulations
  13. HDAC Inhibition as Neuroprotection in COVID-19 Infection
  14. Dihydropyrazole-Carbohydrazide Derivatives with Dual Activity as Antioxidant and Anti-Proliferative Drugs on Breast Cancer Targeting the HDAC6
  15. Synthesis, spectroscopic characterization, molecular docking studies and DFT calculation of novel Mannich base 1-((4-ethylpiperazin-1-yl)(2-hydroxyphenyl)methyl)naphthalen-2-ol
  16. In silico design of HDAC6 inhibitors with neuroprotective effects
  17. Computational study of DMPC liposomes loaded with the N-(2-Hydroxyphenyl)-2-propylpentanamide (HO-AAVPA) and determination of its antiproliferative activity in vitro in NIH-3T3 cells
  18. Targeting Several Biologically Reported Targets of Glioblastoma Multiforme by Assaying 2D and 3D Cultured Cells
  19. Drug repositioning Nsp15 of SARS-COV-2 for treatment of Covid-19
  20. Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population
  21. Docking Approaches Used in Epigenetic Drug Investigations
  22. N-(2′-Hydroxyphenyl)-2-Propylpentanamide (HO-AAVPA) Inhibits HDAC1 and Increases the Translocation of HMGB1 Levels in Human Cervical Cancer Cells
  23. Structural insights into spike protein and its natural variants of SARS-CoV-2 found on Mexican population.
  24. DNA methylation of the RE-1 silencing transcription factor in peripheral blood mononuclear cells and gene expression of antioxidant enzyme in patients with late-onset Alzheimer disease
  25. Hydroxamic acid derivatives as HDAC1, HDAC6 and HDAC8 inhibitors with antiproliferative activity in cancer cell lines
  26. O-Alkyl Hydroxamates Display Potent and Selective Antileishmanial Activity
  27. Exploring the inhibitory activity of valproic acid against the HDAC family using an MMGBSA approach
  28. Identification of the NADP+ Structural Binding Site and Coenzyme Effect on the Fused G6PD::6PGL Protein from Giardia lamblia
  29. Vorinostat, a possible alternative to Metronidazole for the treatment of amebiasis caused by Entamoeba histolytica.
  30. Structural and energetic basis for the inhibitory selectivity of both catalytic domains of dimeric HDAC6
  31. Insights into structural features of HDAC1 and its selectivity inhibition elucidated by Molecular dynamic simulation and Molecular Docking
  32. Design, Synthesis and Biological Evaluation of a Phenyl Butyric Acid Derivative, N-(4-chlorophenyl)-4-phenylbutanamide: A HDAC6 Inhibitor with Anti-proliferative Activity on Cervix Cancer and Leukemia Cells
  33. Searching the conformational complexity and binding properties of HDAC6 through docking and molecular dynamic simulations
  34. Exploring the Potential binding Sites of Some Known HDAC Inhibitors on Some HDAC8 Conformers by Docking Studies
  35. Three Amino Acid Derivatives of Valproic Acid: Design, Synthesis, Theoretical and Experimental Evaluation as Anticancer Agents